Growth Metrics

Crescent Biopharma (CBIO) Profit After Tax Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 65.80%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 17.05%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -290.15%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 59.59%
7 Evaxion A 64.16 Bn 64.14 Bn - -129.68%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -10.08%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1,228.66%
10 Crescent Biopharma 569.36 Mn 380.20 Mn - -53.70%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -53.70%
Dec 31, 2025 -30.41%
Sep 30, 2025 -835.01%
Jun 30, 2025 -115.84%
Mar 31, 2025 -41.09%
Dec 31, 2024 -96.80%
Sep 30, 2024 71.41%
Jun 30, 2024 -22.24%
Mar 31, 2024 -3.64%
Dec 31, 2023 11.38%
Sep 30, 2023 -7.96%
Jun 30, 2023 37.75%
Mar 31, 2023 29.30%
Dec 31, 2022 41.20%
Sep 30, 2022 50.82%
Jun 30, 2022 7.86%
Mar 31, 2022 -2.66%
Dec 31, 2021 -11.95%
Sep 30, 2021 -26.31%
Jun 30, 2021 -2.27%
Mar 31, 2021 -86.28%
Dec 31, 2020 -5.68%
Sep 30, 2020 -3.55%
Jun 30, 2020 11.06%
Mar 31, 2020 45.59%
Dec 31, 2019 -5.89%
Sep 30, 2019 -14.49%
Jun 30, 2019 -40.35%
Mar 31, 2019 -22.33%
Dec 31, 2018 -50.22%
Sep 30, 2018 -45.60%
Jun 30, 2018 -38.53%
Mar 31, 2018 -45.16%
Dec 31, 2017 -11.16%
Sep 30, 2017 -1.21%
Jun 30, 2017 -0.87%
Mar 31, 2017 -4.98%
Dec 31, 2016 6.23%
Sep 30, 2016 -9.58%
Jun 30, 2016 -177.69%
Mar 31, 2016 -6.27%
Dec 31, 2015 -20.12%
Sep 30, 2015 -8.32%
Jun 30, 2015 30.00%
Mar 31, 2015 -39.34%
Dec 31, 2014 -91.19%
Sep 30, 2014 -78.81%
Jun 30, 2014 328.53%
Mar 31, 2014 -1,209.85%